GB1342286A - Treatment of alopecia - Google Patents

Treatment of alopecia

Info

Publication number
GB1342286A
GB1342286A GB913371A GB913371A GB1342286A GB 1342286 A GB1342286 A GB 1342286A GB 913371 A GB913371 A GB 913371A GB 913371 A GB913371 A GB 913371A GB 1342286 A GB1342286 A GB 1342286A
Authority
GB
United Kingdom
Prior art keywords
treatment
dopa
alopecia
compounded
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB913371A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1342286A publication Critical patent/GB1342286A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB913371A 1970-11-06 1971-04-08 Treatment of alopecia Expired GB1342286A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9814670 1970-11-06

Publications (1)

Publication Number Publication Date
GB1342286A true GB1342286A (en) 1974-01-03

Family

ID=14212042

Family Applications (1)

Application Number Title Priority Date Filing Date
GB913371A Expired GB1342286A (en) 1970-11-06 1971-04-08 Treatment of alopecia

Country Status (3)

Country Link
DE (1) DE2117762A1 (https=)
FR (1) FR2112483B1 (https=)
GB (1) GB1342286A (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1348421A3 (fr) * 2002-03-25 2004-01-02 L'oreal Procédé de densification ou de coiffage des fibres kératiniques humaines utilisant un système catalytique particulier
US6696600B2 (en) 2001-11-13 2004-02-24 Teva Pharmaceutical Industries, Ltd. L-DOPA ethyl ester salts and uses thereof
FR2847805A1 (fr) * 2002-11-28 2004-06-04 Oreal Procede de densification des fibres keratiniques humaines utilisant un systeme catalytique particulier

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4021538A (en) * 1975-09-29 1977-05-03 Yu Ruey J Method for producing pigmentation in hair or skin
IT1258069B (it) * 1992-04-10 1996-02-20 Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696600B2 (en) 2001-11-13 2004-02-24 Teva Pharmaceutical Industries, Ltd. L-DOPA ethyl ester salts and uses thereof
EP1348421A3 (fr) * 2002-03-25 2004-01-02 L'oreal Procédé de densification ou de coiffage des fibres kératiniques humaines utilisant un système catalytique particulier
FR2847805A1 (fr) * 2002-11-28 2004-06-04 Oreal Procede de densification des fibres keratiniques humaines utilisant un systeme catalytique particulier

Also Published As

Publication number Publication date
FR2112483B1 (https=) 1975-06-06
DE2117762A1 (de) 1972-05-10
FR2112483A1 (https=) 1972-06-16

Similar Documents

Publication Publication Date Title
NL193819B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
GB1198764A (en) A Urate Oxidase and process for the production thereof
GB1342286A (en) Treatment of alopecia
GB1051268A (en) Hair treating compositions
GB1341794A (en) Medicament for the treatment of hepatic disorders
GB1239965A (en) Cosmetic preparations
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
GB1142220A (en) Skin treatment agent
CA922691A (en) Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
HK57477A (en) 3'-4'-dideoxykanamycin b active against resistant bacteria, and its synthesis
IE35711L (en) Pharmaceutical compositions
GB1337093A (en) Pharmaceutical preparation for the treatment of local oedemas
IE33519L (en) Benzylhydrazides
IE38235B1 (en) Preparations for combatting swine dysentery
GB1430726A (en) Pharmaceutical preparations containing resorcinol deirvatives
GB1292794A (en) Pharmaceutical compositions
GB1279380A (en) Improvements in or relating to hydantoins and compositions thereof
CA849004A (en) Dermatological preparations containing pilosine, isopilosine and their salts
GB1180233A (en) Modified Spiramycin
GB1392004A (en) Propoxyphene salts
IE33520L (en) Benzylhydrazides
GB1475651A (en) Pharmaceutical composition for the treatment of cancer
CA850656A (en) Salts of 4,4'-(disulphoxy-diphenyl), methanes and preparation thereof
CA1021262A (en) Acne preparation for oral administration and process for preparing

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years